Novel targets for immunotherapy in glomerulonephritis
Mary H FosterDepartment of Medicine and Research Service, Duke University Medical Center and Durham Veterans Affairs Medical Center, Durham, North Carolina, USAAbstract: Glomerulonephritis is a common cause of chronic kidney disease and end stage renal failure. Current therapy relies on variably eff...
Guardado en:
Autor principal: | Mary H Foster |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a26cf120cb94ec1ad75138f3cbf9a4e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antineutrophil cytoplasmic antibodies-associated glomerulonephritis: From bench to bedside
por: Yong-Xi Chen, et al.
Publicado: (2018) -
Crescentic glomerulonephritis in a patient with right-sided infective endocarditis
por: F Oliaei, et al.
Publicado: (2002) -
Particle platforms for cancer immunotherapy
por: Serda RE
Publicado: (2013) -
Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature
por: Bounia CA, et al.
Publicado: (2021) -
Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects
por: Ke-Yu Li, et al.
Publicado: (2020)